Azoles
Strem, An Ascensus Company CAS# 141556-42-5. 2g. 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, min. 98%. MFCD09265338
CAS# 141556-42-5. 2g. 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, min. 98%. MFCD09265338. Molecular Weight: 304.43. Molecular Formula: C21H24N2. Color/form: white to off-white pwdr. Strem# 07-0600. http://www.strem.com/catalog/v/07-0600/
Medchemexpress LLC Y-27632 dihydrochloride | 129830-38-2 | MFCD03490488 | 99.9% | 320.26 g/mol | C14H23Cl2N3O | 5 MG
Y-27632 dihydrochloride is an ATP-competitive inhibitor of Rho-associated protein kinases (ROCK) used in research to modulate cytoskeletal dynamics, cell morphology, and motility in vitro and in vivo. It is supplied as a high-purity, white to off-white solid suitable for laboratory assays and preclinical studies.
- ATP-competitive ROCK inhibitor (ROCK-I Ki = 220 nM; ROCK-II Ki = 300 nM).
- Orally active; applicable to in vivo and in vitro studies.
- High purity (≈99.9%) for reproducible experimental results.
- Molecular weight 320.26 g/mol for stoichiometric calculations.
- White to off-white solid; convenient handling and storage.
- Available in small research quantities suitable for assay development.
Medchemexpress LLC Methyl tridecanoate | 1731-88-0 | 228.37 | 1 ML
Methyl tridecanoate moderately inhibits β-amyloid aggregation and weakly inhibits acetylcholinesterase (AChE).
- Moderately inhibits β-amyloid aggregation
- Weakly inhibits acetylcholinesterase (AChE)
eMolecules 1596357-16-2 | Medchem Express | Azilsartan mepixetil | 5mg | 728132615 | HY-145552 | 678.702 | C36H34N6O8
Ambeed | 8-Amino-45-dihydro-1H-benzo[b]azepin-2(3H)-one | 250mg | 490545237 | A258791 | 22246-76-0 | MFCD04038431 | 176.219 | C10H12N2O
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC Atopaxar | 751475-53-3 | 99.9% | 527.63 | 5 MG
Atopaxar is a potent, orally active, selective and reversible thrombin receptor protease-activated receptor-1 (PAR-1) antagonist. As an antiplatelet agent, it interferes with platelet signaling and can be used for the research of atherothrombotic disease.
- Potent, orally active, selective and reversible PAR-1 antagonist
- Interferes with platelet signaling
- Used for research of atherothrombotic disease
- Inhibits human platelet aggregation induced by thrombin or TRAP
- Does not inhibit PRP aggregation induced by ADP, U46619, collagen, and PAR-4ap, up to 20 μM
- Causes dose-dependent prolongation of time to occlusion of the femoral artery in photochemically-induced thrombosis (PIT) guinea pigs model
- Does not prolong bleeding time in guinea pigs at high dosages